Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study.
COVID-19
SARS-CoV-2
alopecia areata
vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
05 Sep 2022
05 Sep 2022
Historique:
received:
08
07
2022
revised:
30
08
2022
accepted:
31
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Limited data concerning the development of autoimmune skin diseases after COVID-19 vaccination are currently available. Recently, a few reports described the development, worsening or recurrence of alopecia areata after the administration of COVID-19 vaccines. High variability in terms of disease onset following vaccination as well as the heterogeneous topical and/or systemic treatment approaches have been described.
Identifiants
pubmed: 36146545
pii: vaccines10091467
doi: 10.3390/vaccines10091467
pmc: PMC9505739
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Dermatol Ther. 2022 Sep;35(9):e15689
pubmed: 35789521
Vaccines (Basel). 2020 Sep 22;8(3):
pubmed: 32971761
J Formos Med Assoc. 2022 Oct;121(10):2138-2140
pubmed: 35379574
JAAD Case Rep. 2022 Jul;25:25-26
pubmed: 35571458
Dermatol Ther. 2021 Jan;34(1):e14691
pubmed: 33351215
Biomed Pharmacother. 2020 Oct;130:110542
pubmed: 32738636
Int J Dermatol. 2022 May;61(5):634-635
pubmed: 35107173
Br J Dermatol. 2018 Nov;179(5):1033-1048
pubmed: 29791718
Clin Immunol. 2021 Mar;224:108665
pubmed: 33429060
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180
pubmed: 34661927
Dermatol Ther. 2021 Nov;34(6):e15113
pubmed: 34453380
Immunology. 2022 Apr;165(4):386-401
pubmed: 34957554
Clin Immunol. 2020 Aug;217:108480
pubmed: 32461193
J Cosmet Dermatol. 2021 Dec;20(12):3727-3729
pubmed: 34559937
J Am Acad Dermatol. 2021 Jul;85(1):46-55
pubmed: 33838206
J Cosmet Dermatol. 2021 Dec;20(12):3753-3757
pubmed: 34741583
J Am Acad Dermatol. 2022 Jan;86(1):113-121
pubmed: 34517079
Clin Exp Vaccine Res. 2022 Jan;11(1):129-132
pubmed: 35223675
JAAD Int. 2022 Jun;7:67-77
pubmed: 35224518
JAAD Case Rep. 2022 Feb;20:1-5
pubmed: 34931171
Contemp Clin Trials. 2022 Apr;115:106700
pubmed: 35149232
Am J Clin Dermatol. 2018 Feb;19(1):119-126
pubmed: 28801732